Concurrent Chemoradiotherapy with Weekly Paclitaxel in Malignant Cerebral Glioma Treatment

Publisher： Karger

E-ISSN： 2296-5262|31|8-9|435-439

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.8-9, 2008-08, pp. : 435-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concurrent Chemoradiotherapy for Malignant Glioma: Dead End or Highway?

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-08 ,pp. : 430-431

Karger

Access to resources Recommend Favorite

Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 40-46

Karger

Access to resources Recommend Favorite

Comparison of efficacy and toxicity profiles between paclitaxel/lobapoatin‐ and cisplatin/5‐fluorouracil‐based concurrent chemoradiotherapy of advanced inoperable oesophageal cancer

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 7, 2015-07 ,pp. : 757-761

John Wiley & Sons Inc

Access to resources Recommend Favorite

Concurrent Chemoradiotherapy with Low-Dose Cisplatin plus 5-Fluorouracil for the Treatment of Patients with Unresectable Head and Neck Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Two year survival after malignant cerebral glioma: patient and relative reports of handicap, psychiatric symptoms and rehabilitation

By DAVIES E.   HALL S.   CLARKE C.  

Disability and Rehabilitation, Vol. 25, Iss. 6, 2003-03 ,pp. : 259-266

Informa Healthcare

Access to resources Recommend Favorite